Christoph MassnerPartner at Earlybird Venture CapitalSpeaker
Profile
Dr. Christoph Massner is a Partner at Earlybird Health and brings a commercial-led mindset shaped by work across therapeutics, data-enabled health technologies, platform tools, and diagnostics.
Since joining Earlybird in 2018, he has led several transactions across Earlybird Health I & II, focusing on business models that translate tech into healthcare. He is known for articulating how data and AI create value in patient care and product development.
Chris serves as Board Director of Hilo (Aktiia), and holds board observer roles at Shape Memory Medical and Alesi Surgical. Beyond portfolio work, he actively builds bridges between tech investors, corporates, and our health portfolio.
Agenda Sessions
AI-Powered Ecosystems: Transforming Drug Discovery Through Digital Collaboration
, 13:00View Session
